News

Eli Lilly’s Mounjaro shows cardiovascular gains, but analysts underwhelmed

Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.
PharmExec2h

Eli Lilly and Company’s Mounjaro Displayed Cardiovascular Protection in New Head-to-Head Trial

Eli Lilly's Mounjaro shows significant cardiovascular benefits in a major trial enhancing treatment options for type 2 ...
The Pharma Letter1h

Lilly's Mounjaro demonstrates cardiovascular protection

US pharma major Eli Lilly has announced top-line results from SURPASS-CVOT, a first-of-its-kind head-to-head Phase III ...

Lilly stock falls as Mounjaro fails to show superiority over Trulicity

Eli Lilly and Company (NYSE:LLY) stock fell on Thursday morning after the pharmaceutical giant’s diabetes drug Mounjaro ...
Devdiscourse21h

Mounjaro Overshadows Trulicity in Life-Saving Diabetes Battle

Eli Lilly's Mounjaro diabetes drug has demonstrated superior performance over Trulicity in reducing heart attack and stroke ...

I’m on Mounjaro & here’s what happens after drinking on fat jabs – the hangxiety & acid reflux is the worst for starters

A WOMAN has revealed the awful side effects she has experienced when drinking on Mounjaro. Since becoming available on the ...
Tyla2d

Mounjaro user revealed how she got over 'nightmare' side effect that no one warned her about

"The Mounjaro (tirzepatide) Patient Information Leaflet warns that hair loss is a common side effect in patients treated with ...